Nuclear Medicine: Page 77

SNMMI schedules training forum for annual meeting

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) will host a special session on the training path for nuclear medicine physicians during its annual meeting in Philadelphia next month.

May 23, 2018

SNMMI offers open access option for JNM

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has made available an immediate open access option for researchers submitting articles to the Journal of Nuclear Medicine.

May 21, 2018

PET links amyloid, vascular factors to cognitive decline

By AuntMinnie.com staff writers

PET scans of normal older adults can detect which ones are likely to decline cognitively at a faster rate based on levels of amyloid and other risk factors, according to a study published online May 21 in JAMA Neurology.

May 21, 2018

Blue Earth promotes results for PET/CT agent

By AuntMinnie.com staff writers

Molecular imaging firm Blue Earth Diagnostics is touting results from an investigational clinical trial with its Axumin F-18 fluciclovine PET/CT radiopharmaceutical.

May 20, 2018

SNMMI seeks to boost molecular imaging's value

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is looking to boost the value of nuclear medicine and molecular imaging with the creation of the Value Initiative Industry Alliance.

May 17, 2018

Bone scan software predicts prostate cancer survival

By Brian Casey

Researchers using automated software to assess bone scintigraphy scans of patients with metastatic prostate cancer found that the algorithm helped them predict which patients were more likely to survive, compared with manual methods of interpreting the scans, according to a May 17 paper in JAMA Oncology.

May 16, 2018

Immuno-PET tracer offers hope for early cancer treatment

By Wayne Forrest

Researchers are developing a PET radiotracer designed to adhere to and illuminate immune cells in cancer patients. They believe it could offer an earlier look at treatment response compared with tracers such as FDG that focus on cancer cells, according to a study published May 14 in the Journal of Clinical Investigation.

May 16, 2018

Canadian cyclotron could address isotope supply issues

By AuntMinnie.com staff writers

After years of development, researchers at the University of Alberta have succeeded in creating an environmentally friendly cyclotron that can produce enough medical isotopes for as many as 1,000 imaging scans a day.

May 14, 2018

PET with novel tracers foretells early Alzheimer's risk

By Wayne Forrest

Researchers are making strides toward discovering which individuals have an increased risk of Alzheimer's disease thanks to two novel PET radiotracers that show increased uptake in key regions of the brain, according to two studies published online May 14 in JAMA Neurology.

May 14, 2018

PET may help spot protein clumps in heart disease

By AuntMinnie.com staff writers

Using preclinical PET and other techniques, researchers appear to have found a connection between the accumulation of protein clumps and heart failure in mice, according to results published in the May 11 issue of Circulation Research. By visualizing the protein, PET could eventually prove useful for monitoring and treating heart disease in humans, the group believes.

May 10, 2018

Curium to market xenon-133 gas in the U.S.

By AuntMinnie.com staff writers

Global nuclear medicine firm Curium has expanded its U.S. offerings to include xenon-133 gas, sourced from its Petten manufacturing facility in the Netherlands and using low-enriched uranium targets.

May 9, 2018

Blue Earth expands PSMA-PET/CT imaging portfolio

By AuntMinnie.com staff writers

Molecular imaging firm Blue Earth Diagnostics has signed an agreement for exclusive rights to radiopharmaceutical technology firm Scintomic's "radiohybrid" prostate-specific membrane antigen (rhPSMA-7) imaging agent.

May 6, 2018

Previous Page

Page 77 of 438

Next Page